Trials & R&D · first seen 16h ago, updated 16h ago
How radioligand therapy is rewriting cancer care
In this episode of Denatured presented by Curium, Jennifer Smith-Parker speaks to Mike Patterson, CEO North America and Professor Sabine Brookman-May, vice president and head of Global Clinical Development. We look at the momentum behind ra…
Summary from BioSpace - All News.
Coverage 1 article · 1 outlet
-
BioSpace - All NewsHow radioligand therapy is rewriting cancer care